INVO Fertility, Inc.

We are a healthcare services and technology company focused on the fertility marketplace and dedicated to expanding access to assisted reproductive technology (“ART”) care to patients in need. Our principal commercial strategy is focused on acquiring, establishing, and operating fertility clinics and related businesses and technologies. Our acquisition strategy focuses on US-based, profitable fertility clinics. Our clinics offer a variety of fertility services including in vitro fertilization (“IVF”) and the intravaginal culture (“IVC”) procedure enabled by our INVOcell® medical device (“INVOcell”).  As of the date of this filing, we have four fertility clinics in the United States. We also continue to engage in the sale and distribution of our INVOcell technology solution into third-party owned and operated fertility clinics. We also intend to seek out additional, innovative fertility-focused technologies, to license or acquire in order to utilize within our clinics.

Current securities

1. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other EventsNov 4, 2026
2. SCHEDULE 13G/A - filed by GLENBROOK CAPITAL MANAGEMENT regarding INVO Fertility, Inc.Oct 9, 2026
3. S-8 filingAug 28, 2026
4. Regulation FD Disclosure · Other EventsAug 28, 2026
5. Results of Operations and Financial ConditionAug 17, 2026